Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2020. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3789100013 | Caplacizumab-containing product in parenteral dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3789101012 | Product containing caplacizumab in parenteral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Caplacizumab-containing product in parenteral dose form | a une forme pharmaceutique (attribut) | forme pharmaceutique pour usage parentéral (forme pharmaceutique) | true | Inferred relationship | Some | ||
| Caplacizumab-containing product in parenteral dose form | est un(e) (attribut) | Product manufactured as parenteral dose form (product) | true | Inferred relationship | Some | ||
| Caplacizumab-containing product in parenteral dose form | a pour principe actif (attribut) | Caplacizumab (substance) | true | Inferred relationship | Some | 1 | |
| Caplacizumab-containing product in parenteral dose form | est un(e) (attribut) | Caplacizumab-containing product | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Caplacizumab only product in parenteral dose form | est un(e) (attribut) | True | Caplacizumab-containing product in parenteral dose form | Inferred relationship | Some |
Reference Sets
Canada English language reference set (foundation metadata concept)
FHIR